203 related articles for article (PubMed ID: 15785013)
21. Should increasing the dose or adding an AT1 receptor blocker follow a relatively low dose of ACE inhibitor initiated in acute myocardial infarction?
Sugie T; Kagaya Y; Takeda M; Yahagi H; Takahashi C; Takahashi J; Ninomiya M; Watanabe J; Ichinohasama R; Tezuka F; Shirato K
Cardiovasc Res; 2003 Jun; 58(3):611-20. PubMed ID: 12798434
[TBL] [Abstract][Full Text] [Related]
22. Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats.
Emoto N; Raharjo SB; Isaka D; Masuda S; Adiarto S; Jeng AY; Yokoyama M
Hypertension; 2005 Jun; 45(6):1145-52. PubMed ID: 15897363
[TBL] [Abstract][Full Text] [Related]
23. The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: the OLCA study.
Daikuhara H; Kikuchi F; Ishida T
Diab Vasc Dis Res; 2012 Oct; 9(4):280-6. PubMed ID: 22718810
[TBL] [Abstract][Full Text] [Related]
24. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H
Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
[TBL] [Abstract][Full Text] [Related]
25. Effects of combination of angiotensin receptor blocker and calcium channel blocker on ox-LDL levels and cardiovascular dysfunction in Dahl rats.
Takayama M; Arakawa E; Yao K; Ina Y; Sato H; Hasegawa K; Kohno H; Ohno T
Pharmacology; 2006; 77(4):179-87. PubMed ID: 16864986
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Kim S; Zhan Y; Izumi Y; Iwao H
Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
[TBL] [Abstract][Full Text] [Related]
28. Effects of angiotensin AT1 receptor antagonist on volume overload-induced cardiac gene expression in rats.
Kim S; Sada T; Mizuno M; Ikeda M; Yano M; Miura K; Yamanaka S; Koike H; Iwao H
Hypertens Res; 1997 Jun; 20(2):133-42. PubMed ID: 9220278
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats.
Ohnishi K; Murase M; Nakano D; Pelisch N; Hitomi H; Kobori H; Morimoto S; Mori H; Masaki T; Ohmori K; Kohno M; Ichihara A; Nishiyama A
J Pharmacol Sci; 2013; 122(2):103-8. PubMed ID: 23698111
[TBL] [Abstract][Full Text] [Related]
30. The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet.
Aritomi S; Koganei H; Wagatsuma H; Mitsui A; Ogawa T; Nitta K; Konda T
Heart Vessels; 2010 Nov; 25(6):549-55. PubMed ID: 20922532
[TBL] [Abstract][Full Text] [Related]
31. Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats.
Nakamoto T; Harasawa H; Akimoto K; Hirata H; Kaneko H; Kaneko N; Sorimachi K
Eur J Pharmacol; 2005 Dec; 528(1-3):43-51. PubMed ID: 16336959
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
[TBL] [Abstract][Full Text] [Related]
33. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study.
Matsui Y; O'Rourke MF; Hoshide S; Ishikawa J; Shimada K; Kario K
Hypertension; 2012 Jun; 59(6):1132-8. PubMed ID: 22547439
[TBL] [Abstract][Full Text] [Related]
34. Synergistic neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke-prone spontaneously hypertensive rats.
Omote Y; Deguchi K; Kono S; Liu W; Kurata T; Hishikawa N; Yamashita T; Ikeda Y; Abe K
J Neurosci Res; 2014 Oct; 92(10):1330-7. PubMed ID: 24839960
[TBL] [Abstract][Full Text] [Related]
35. Combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and a calcium antagonist: beyond the renoprotective effects of ACE inhibitor monotherapy in a spontaneous hypertensive rat with renal ablation.
Kanazawa M; Kohzuki M; Yoshida K; Kurosawa H; Minami N; Saito T; Yasujima M; Abe K
Hypertens Res; 2002 May; 25(3):447-53. PubMed ID: 12135325
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.
Ishimitsu T; Numabe A; Masuda T; Akabane T; Okamura A; Minami J; Matsuoka H
Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778
[TBL] [Abstract][Full Text] [Related]
37. Anti-atherogenic effects of the combination therapy with olmesartan and azelnidipine in diabetic apolipoprotein E-deficient mice.
Noda K; Hosoya M; Nakajima S; Ohashi J; Fukumoto Y; Shimokawa H
Tohoku J Exp Med; 2012 Dec; 228(4):305-15. PubMed ID: 23124103
[TBL] [Abstract][Full Text] [Related]
38. Prevention of vascular injury by combination of an AT1 receptor blocker, olmesartan, with various calcium antagonists.
Inaba S; Iwai M; Tomono Y; Senba I; Furuno M; Kanno H; Okayama H; Mogi M; Higaki J; Horiuchi M
Am J Hypertens; 2009 Feb; 22(2):145-50. PubMed ID: 19057515
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous treatment with azelnidipine and olmesartan inhibits apoptosis of Hl-1 cardiac myocytes expressing E334k cMyBPC.
Bahrudin U; Ikeda N; Utami SB; Maharani N; Morikawa K; Li P; Sobirin MA; Hasegawa A; Sakata S; Endo R; Rifqi S; Shirayoshi Y; Yamamoto K; Ninomiya H; Hisatome I
Drug Res (Stuttg); 2013 Oct; 63(10):515-20. PubMed ID: 23740383
[TBL] [Abstract][Full Text] [Related]
40. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
Nagata K; Somura F; Obata K; Odashima M; Izawa H; Ichihara S; Nagasaka T; Iwase M; Yamada Y; Nakashima N; Yokota M
Hypertension; 2002 Aug; 40(2):168-74. PubMed ID: 12154108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
